Marine Joseph E JE

Show results for

Unknown (3)
Metabolomics (2)

Repository

MetaboLights (2)

Technology Type

Mass spectrometry (2)

Instrument Platform

Tandem Gas Chromatography MS - positive (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)

Publication Date

2021 (1)
2018 (1)

CHEBI ID

CHEBI:19203 (1)
CHEBI:84249 (1)
CHEBI:142658 (1)
CHEBI:142657 (1)
CHEBI:16310 (1)
CHEBI:84222 (1)

Metabolite Name

4,6-Dimethyl-dodecane (1)
1-Iodo-2-methylundecane (1)
6-Methyl-5-hepten-2-one (1)
TAG 59:12 (15:0/22:6/22:6) (1)
TAG 55:7 (15:0/18:1/22:6) (1)
TAG 55:6 (15:0/18:0/22:6) (1)
TAG 55:1 (15:0/18:1/22:0) (1)
TAG 53:6 (15:0/16:0/22:6) (1)
TAG 53:4 (15:0/18:1/20:3) (1)
TAG 51:5 (15:0/18:1/18:4) (1)
TAG 51:4 (15:0/18:1/18:3) (1)
TAG 51:3 (15:0/18:1/18:2) (1)
TAG 51:2 (15:0/18:1/18:1) (1)
TAG 51:1 (15:0/18:0/18:1) (1)
TAG 49:1 (15:0/16:0/18:1) (1)
TAG 48:1 (14:0/16:0/18:1) (1)
TAG 48:1 (15:0/15:0/18:1) (1)
TAG 47:1 (14:0/15:0/18:1) (1)
PC 37:6 (15:0/22:6) (1)
Pyrrole (1)

Release Date

2025 (3)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

A Metabolomic Approach for Predicting Diurnal Changes in Cortisol

INTRODUCTION: The dysregulation of cortisol secretion has been associated with a number of mental health and mood disorders. However, diagnostics for mental health and mood disorders are behavioral and lack biological contexts.

OBJECTIVES: The goal of this ...

2021-09-23 | MTBLS1206 | MetaboLights

In plaque-mass spectrometry imaging of a bloom-forming alga during viral infection reveals a metabolic shift towards odd-chain fatty acid lipids (GC- and LC-MS assays)

Tapping into the metabolic cross-talk between a host and its virus can reveal unique strategies employed during infection. Viral infection is a dynamic process that generates an evolving metabolic landscape. Gaining a continuous view into the infection process is highly challenging and is limited...

2018-11-29 | MTBLS767 | MetaboLights

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.

Not available

S-EPMC12535839 | biostudies-literature

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Not available

S-EPMC12535840 | biostudies-literature

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Not available

S-EPMC12535838 | biostudies-literature